MedTrace Logo

Ceribell Delirium Data Collection Study

NCT04962815 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-07-25

No results posted yet for this study

Summary

This study is designed as a prospective, non-randomized, observational clinical study. The study will collect clinical and rrEEG (Ceribell EEG) data when monitoring subjects for delirium subtypes. EEG and clinical data will be collected for the development of future software algorithms to assess the presence and severity of delirium.

Conditions

  • Delirium

Interventions

DEVICE

Electroencephalogram (EEG) Test

EEG test and delirium assessments will be performed on subjects experiencing delirium in the ICU.

Sponsors & Collaborators

  • Ceribell Inc.

    lead INDUSTRY

Principal Investigators

  • Jose Maldonado, MD · Stanford University

  • Timothy Girard, MD · University of Pittsburgh

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-10
Primary Completion
2025-12-31
Completion
2026-04-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04962815 on ClinicalTrials.gov